Scientists have discovered that the cells linked to Alzheimer’s disease are far more diverse than previously thought. In a new study, researchers examined what’s…
Being Patient Senior Reporter Phil Gutis spent the day with our patient advisor, Jeff Borghoff, who was the first recipient in Biogen’s latest trial…
The study was in mice and the findings are still very preliminary, but researchers at Case Western University School of Medicine have identified a…
A new study by Houston Methodist scientists finds that a protein linked to ovarian cancer may contribute to the development of Alzheimer’s disease. The…
Early detection of dementia and Alzheimer’s disease can help patients get the care and help they need sooner rather than later, but there is…
While scientists remain far from finding a cure for dementia in its many forms, researchers are continuing to make slow-but-steady progress toward identifying potential…
Biogen has agreed to buy an experimental Alzheimer’s and Parkinson’s treatment from Pfizer, the company announced Monday. In the agreed deal, Biogen will pay…
Follow us